Latest News Ampio Pharmaceuticals Announces Update of STRIDE Study for the Investigation of Pain Associated with OsteoarthritisDate: June 4, 2015 | READ MORE > Ampio Pharmaceuticals Announces Positive Study Results on Optina for the Treatment of Diabetic Macular EdemaDate: May 21, 2015 | READ MORE > Ampio Announces Top-Line Results of the Double-Blind Multiple Intra-Articular Injections (STRUT) Study of Ampion™ in Patients with Moderate to Severe Osteoarthritis of the KneeDate: February 25, 2015 | READ MORE > Ampio Updates Status of Clinical Trials and Manufacturing FacilityDate: November 12, 2014 | READ MORE > Ampio Pharmaceuticals announces the FDA has issued a written response and accepted the Ampio plan for beginning production of Ampion™ in the new facilityDate: July 30, 2014 | READ MORE > Ampio Receives FDA Confirmation that The Spring Study is Pivotal and Will Initiate the Final Pivotal Trial for Ampion™ Biological License Application (BLA)Date: December 2, 2013 | READ MORE > Ampio Pharmaceuticals, Inc. Announces Positive Results for Ampion in Osteoarthritis of the Knee Clinical TrialDate: August 14, 2013 | READ MORE >
